Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis

BACKGROUND: Myocarditis is a rare but life-threatening adverse event of cancer treatments with immune checkpoint inhibitors (ICIs). Recent guidelines recommend the use of high doses of corticosteroids as a first-line treatment, followed by intensified immunosuppressive therapy (IIST) in the case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cautela, Jennifer, Zeriouh, Sarah, Gaubert, Melanie, Bonello, Laurent, Laine, Marc, Peyrol, Michael, Paganelli, Franck, Lalevee, Nathalie, Barlesi, Fabrice, Thuny, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725077/
https://www.ncbi.nlm.nih.gov/pubmed/33298621
http://dx.doi.org/10.1136/jitc-2020-001887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725077/
https://www.ncbi.nlm.nih.gov/pubmed/33298621
http://dx.doi.org/10.1136/jitc-2020-001887

Ejemplares similares